Cohance Lifesciences Ltd.

NSE: COHANCE | BSE: 543064

Expensive Performer

Download real time

898.35 29.15 (3.35%)

Near 52W Low of ₹856.00

351.4K NSE+BSE Volume

NSE 16 Oct, 2025 3:31 PM (IST)

34,367.9

Market Cap

High in industry

0.6

Beta 1Year

Very Low volatility

Cohance Lifesciences Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for COHANCE, BSE:543064 Cohance Lifesciences Ltd.

VOTE: Is Suven Pharmaceuticals Ltd. worth buying?

28 Votes:

Buy 64.29%

Sell 17.86%

Hold 17.86%

RESEARCH REPORTS

Buy SEE REPORTS >

Buy SEE REPORTS >